Last reviewed · How we verify
Tailored Group
The drug works by modulating the immune system to treat various conditions.
The drug works by modulating the immune system to treat various conditions. Used for Treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
At a glance
| Generic name | Tailored Group |
|---|---|
| Also known as | "Rabeprazole"" Pariet®", "Esomeprazole"" Nexium®", "Metronidazole""Yabao®", "Amoxicillin""Tongdamoxing®" |
| Sponsor | Beijing Children's Hospital |
| Drug class | Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
It does this by enhancing the body's natural immune response to fight off infections and diseases. This is achieved through a complex interplay of immune cells and signaling pathways.
Approved indications
- Treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Common side effects
- Fatigue
- Headache
- Nausea
Key clinical trials
- The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. (NA)
- The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis (NA)
- Effect of an Audio Instructional Program Regarding Puberty on Self-Concept and Healthy Behaviors of Teenage Girls With Visual Impairment (NA)
- Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer (NA)
- Population Health Approach to Optimizing Medications in Older Adults (NA)
- SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid (NA)
- The Trans-Led Care Study (NA)
- Personalised Active Self-management of Sleep Apnea Program (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |